Systemic, but not intrathecal ketorolac is antinociceptive to uterine cervical distension in rats

[1]  T. Yaksh,et al.  Phase I safety assessment of intrathecal ketorolac , 2002, Pain.

[2]  A. Sandner-Kiesling,et al.  Pharmacology of Opioid Inhibition to Noxious Uterine Cervical Distension , 2002, Anesthesiology.

[3]  J. Eisenach,et al.  Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury , 2002, Brain Research.

[4]  R. James,et al.  Effect of kappa opioid agonists on visceral nociception induced by uterine cervical distension in rats , 2002, Pain.

[5]  A. Sandner-Kiesling,et al.  Estrogen Reduces Efficacy of μ- but Not κ-Opioid Agonist Inhibition in Response to Uterine Cervical Distension , 2002 .

[6]  P. Isakson,et al.  The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1 , 2001, The Journal of Neuroscience.

[7]  R. Fillingim,et al.  Sex-related hormonal influences on pain and analgesic responses , 2000, Neuroscience & Biobehavioral Reviews.

[8]  M. Southall,et al.  Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices , 1998, Pain.

[9]  G. Lauretti,et al.  Epidural nonsteroidal antiinflammatory drugs for cancer pain. , 1998, Anesthesia and analgesia.

[10]  J. Horn,et al.  Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat , 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[11]  J. G. Collins,et al.  Intrathecal prostaglandin E1 produces a long-lasting allodynic state , 1995, Pain.

[12]  T. Yaksh,et al.  Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  Clifford J. Woolf,et al.  Sensitization of high mechanothreshold superficial dorsal horn and flexor motor neurones following chemosensitive primary afferent activation , 1994, Pain.

[14]  O. Hayaishi,et al.  Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice , 1994, Pain.

[15]  G. Gebhart,et al.  Ketorolac Potentiates Morphine Antinociception during Visceral Nociception in the Rat , 1994, Anesthesiology.

[16]  I. Trotman,et al.  Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related pain. , 1994, Postgraduate medical journal.

[17]  A. Malmberg,et al.  Pharmacology of the Spinal Action of Ketorolac, Morphine, ST-91, U50488H, and L-PIA on the Formalin Test and an Isobolographic Analysis of the NSAID Interaction , 1993, Anesthesiology.

[18]  A. Malmberg,et al.  Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. , 1992, The Journal of pharmacology and experimental therapeutics.

[19]  A. Malmberg,et al.  Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. , 1992, Science.

[20]  G. McEvoy,et al.  Ketorolac, an injectable nonnarcotic analgesic. , 1990, Clinical pharmacy.

[21]  R. N. Brogden,et al.  Ketorolac , 2012, Drugs.

[22]  L. Tanenbaum,et al.  The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. , 1985, Drugs under experimental and clinical research.

[23]  C. Woolf.  Evidence for a central component of post-injury pain hypersensitivity , 1983, Nature.

[24]  S. Ferreira,et al.  The hyperalgesic effects of prostacyclin and prostaglandin E2. , 1978, Prostaglandins.

[25]  T. Yaksh,et al.  Chronic catheterization of the spinal subarachnoid space , 1976, Physiology & Behavior.